https://www.selleckchem.com/products/lys05.html
Abnormal coagulation parameters and potential benefits of anticoagulant therapy in general population with novel coronavirus pneumonia (COVID-19) have been reported. However, limited data are available on cancer patients. Coagulation indexes and inflammation parameters in 57 cancer patients with SARS-CoV-2 infection with different severity were retrospectively analyzed. We found that D-dimer levels were increased in 33 patients (57.9%, median 790 ng/mL). Compared with ordinary type patients, severe and critical ill patients had decreased
Like
Comment
Share
